<DOC>
	<DOCNO>NCT00623623</DOCNO>
	<brief_summary>This study aim evaluate , proof concept approach , outcome patient present acute ST-elevation myocardial infarction within 3 hour symptom onset either pre-hospital setting community hospital emergency room without PCI facility . Following randomisation strategy early tenecteplase additional antiplatelet antithrombin therapy follow catheterisation within 6-24 hour timely coronary intervention appropriate ( rescue coronary intervention require ) Group A compare primary PCI perform accord local standard Group B . The study exploratory nature examine medical question . The efficacy safety endpoint well mixed ( efficacy safety ) composite endpoint 30 day follow randomisation evaluate . All clinical endpoint main interest assess single composite endpoint evaluation trial objective . All statistical test exploratory nature base descriptive p-values formal statistical hypothesis generation .</brief_summary>
	<brief_title>STREAM-Strategic Reperfusion ( With Tenecteplase Antithrombotic Treatment ) Early After Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Tenecteplase</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Inclusion criterion : 1 . Age equal great 18 year 2 . Onset symptoms &lt; 3 hour prior randomisation 3.12lead ECG indicative acute STEMI 4.Informed consent receive Exclusion criterion : Medical history , procedure , medication administration presence factor would general predispose bleed event and/or inability evaluate study primary endpoint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>